Kangji Medical Holdings Limited
HKEX:9997.HK
5.28 (HKD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 926.023 | 786.367 | 690.263 | 511.49 | 503.467 | 353.67 | 247.506 |
| Kosten van de omzet
| 184.824 | 151.12 | 127.337 | 80.02 | 80.292 | 64.373 | 47.801 |
| Brutowinst
| 741.199 | 635.247 | 562.926 | 431.47 | 423.175 | 289.297 | 199.705 |
| Brutowinstmarge
| 0.8 | 0.808 | 0.816 | 0.844 | 0.841 | 0.818 | 0.807 |
| Onderzoek- en ontwikkelingskosten
| 127.554 | 66.019 | 36.001 | 25.22 | 17.377 | 14.859 | 10.477 |
| Algemene en administratieve kosten
| 100.269 | 70.892 | 62.06 | 45.688 | 25.579 | 12.588 | 8.072 |
| Verkoop- en marketingkosten
| 69.842 | 53.372 | 46.515 | 48.894 | 41.355 | 20.506 | 11.826 |
| Verkoop-, algemene en administratieve kosten
| 170.111 | 123.21 | 109.189 | 94.582 | 67 | 33.094 | 19.898 |
| Overige kosten
| -6.384 | -26.466 | -3.692 | -25.55 | -1.155 | 0.061 | -3.718 |
| Bedrijfskosten
| 240.221 | 140.231 | 79.818 | 138.497 | 48.677 | 40.745 | 34.514 |
| Bedrijfsresultaat
| 442.47 | 446.018 | 417.736 | 311.668 | 338.798 | 260.545 | 162.64 |
| Bedrijfsresultaat ratio
| 0.478 | 0.567 | 0.605 | 0.609 | 0.673 | 0.737 | 0.657 |
| Totaal overige inkomsten en kosten netto
| 146.301 | 117.126 | 116.761 | -1.593 | 52.396 | 0.614 | -0.468 |
| Inkomen voor belasting
| 588.771 | 563.144 | 534.497 | 310.075 | 391.194 | 261.159 | 162.172 |
| Inkomen voor belasting ratio
| 0.636 | 0.716 | 0.774 | 0.606 | 0.777 | 0.738 | 0.655 |
| Belastingkosten
| 136.476 | 101.97 | 77.708 | 50.925 | 64.459 | 37.366 | 23.695 |
| Nettowinst
| 504.021 | 478.735 | 456.789 | 250.296 | 206.444 | 146.701 | 117.705 |
| Nettowinstmarge
| 0.544 | 0.609 | 0.662 | 0.489 | 0.41 | 0.415 | 0.476 |
| WPA (Winst Per Aandeel)
| 0.43 | 0.4 | 0.37 | 0.26 | 0.2 | 0.12 | 0.094 |
| Verwaterde WPA
| 0.43 | 0.4 | 0.37 | 0.26 | 0.2 | 0.12 | 0.094 |
| EBITDA
| 619.438 | 460.532 | 427.251 | 319.142 | 345.196 | 266.806 | 169.113 |
| EBITDA ratio
| 0.669 | 0.586 | 0.619 | 0.624 | 0.686 | 0.754 | 0.683 |